151 related articles for article (PubMed ID: 32729791)
21. Changing trend of Epstein-Barr virus association in Hodgkin lymphoma in the Republic of Korea.
Koh YW; Kang HJ; Yoon DH; Suh C; Kim JE; Kim CW; Huh J
Ann Hematol; 2013 Dec; 92(12):1653-60. PubMed ID: 23832190
[TBL] [Abstract][Full Text] [Related]
22. Grey zone lymphoma with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a clinicopathological study of 14 Epstein-Barr virus-positive cases.
Elsayed AA; Satou A; Eladl AE; Kato S; Nakamura S; Asano N
Histopathology; 2017 Mar; 70(4):579-594. PubMed ID: 27735994
[TBL] [Abstract][Full Text] [Related]
23. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
[TBL] [Abstract][Full Text] [Related]
25. Cell-free epstein-barr viral loads in childhood hodgkin lymphoma: a study from South India.
Sinha M; Rao CR; Shafiulla M; Appaji L; Bs AK; Sumati BG; Avinash T; Jayshree RS
Pediatr Hematol Oncol; 2013 Sep; 30(6):537-43. PubMed ID: 23756088
[TBL] [Abstract][Full Text] [Related]
26. Exposure to childhood infections and risk of Epstein-Barr virus--defined Hodgkin's lymphoma in women.
Glaser SL; Keegan TH; Clarke CA; Trinh M; Dorfman RF; Mann RB; DiGiuseppe JA; Ambinder RF
Int J Cancer; 2005 Jul; 115(4):599-605. PubMed ID: 15700307
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.
Urayama KY; Jarrett RF; Hjalgrim H; Diepstra A; Kamatani Y; Chabrier A; Gaborieau V; Boland A; Nieters A; Becker N; Foretova L; Benavente Y; Maynadié M; Staines A; Shield L; Lake A; Montgomery D; Taylor M; Smedby KE; Amini RM; Adami HO; Glimelius B; Feenstra B; Nolte IM; Visser L; van Imhoff GW; Lightfoot T; Cocco P; Kiemeney L; Vermeulen SH; Holcatova I; Vatten L; Macfarlane GJ; Thomson P; Conway DI; Benhamou S; Agudo A; Healy CM; Overvad K; Tjønneland A; Melin B; Canzian F; Khaw KT; Travis RC; Peeters PH; González CA; Quirós JR; Sánchez MJ; Huerta JM; Ardanaz E; Dorronsoro M; Clavel-Chapelon F; Bueno-de-Mesquita HB; Riboli E; Roman E; Boffetta P; de Sanjosé S; Zelenika D; Melbye M; van den Berg A; Lathrop M; Brennan P; McKay JD
J Natl Cancer Inst; 2012 Feb; 104(3):240-53. PubMed ID: 22286212
[TBL] [Abstract][Full Text] [Related]
28. Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan.
Chang KC; Chen PC; Jones D; Su IJ
Cancer Sci; 2008 Feb; 99(2):345-9. PubMed ID: 18201268
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of CD20 expression and Epstein-Barr virus (EBV) association in classical Hodgkin lymphoma in Japan: a clinicopathologic study.
Elsayed AA; Asano N; Ohshima K; Izutsu K; Kinoshita T; Nakamura S
Pathol Int; 2014 Jul; 64(7):336-45. PubMed ID: 25047504
[TBL] [Abstract][Full Text] [Related]
30. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients.
Asano N; Yamamoto K; Tamaru J; Oyama T; Ishida F; Ohshima K; Yoshino T; Nakamura N; Mori S; Yoshie O; Shimoyama Y; Morishima Y; Kinoshita T; Nakamura S
Blood; 2009 Mar; 113(12):2629-36. PubMed ID: 19075188
[TBL] [Abstract][Full Text] [Related]
31. Hodgkin lymphoma in Pakistan: an analysis of subtypes and their correlation with Epstein Barr virus.
Fatima S; Ahmed R; Ahmed A
Asian Pac J Cancer Prev; 2011; 12(6):1385-8. PubMed ID: 22126469
[TBL] [Abstract][Full Text] [Related]
32. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
[TBL] [Abstract][Full Text] [Related]
33. [Infection status and prognostic significance analysis of Epstein-Barr virus in 207 cases with newly diagnosed Hodgkin's lymphoma].
Kang S; Qin Y; He X; Zhou S; Han X; Liu P; Dong M; Zhou L; Yang J; Yang S; Zhang C; Gui L; Shi Y
Zhonghua Yi Xue Za Zhi; 2015 Aug; 95(32):2594-8. PubMed ID: 26711606
[TBL] [Abstract][Full Text] [Related]
34. Association of DDX58 177 C > T polymorphism with decreased risk of Epstein-Barr virus-related nodular sclerosis classical Hodgkin lymphoma.
Martin P; Martínez-Velasquez J; Coronado MJ; Krsnik I; Provencio M; Navarro B; Moraru M; Bellas C; Vilches C; Gomez-Lozano N
Leuk Lymphoma; 2017 Feb; 58(2):438-444. PubMed ID: 27267403
[TBL] [Abstract][Full Text] [Related]
35. A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.
Delahaye-Sourdeix M; Urayama KY; Gaborieau V; Veenstra R; Foll M; Chabrier A; Benavente Y; Nieters A; Becker N; Foretova L; Maynadié M; Staines A; Smedby KE; Glimelius I; Lightfoot T; Cocco P; Galan P; Vatten LJ; Duell EJ; Kiemeney L; Roman E; de Sanjosé S; Lathrop M; Melbye M; Brennan P; Diepstra A; van den Berg A; Hjalgrim H; Jarrett RF; McKay JD
Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1838-43. PubMed ID: 26404960
[TBL] [Abstract][Full Text] [Related]
36. Infectious, autoimmune and allergic diseases and risk of Hodgkin lymphoma in children and adolescents: a Children's Oncology Group study.
Linabery AM; Erhardt EB; Fonstad RK; Ambinder RF; Bunin GR; Ross JA; Spector LG; Grufferman S
Int J Cancer; 2014 Sep; 135(6):1454-69. PubMed ID: 24523151
[TBL] [Abstract][Full Text] [Related]
37. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus in biopsies from patients with Hodgkin and non-Hodgkin lymphoma at the University of Puerto Rico immunohistochemistry laboratory.
Córdova Pérez FJ; González-Keelan CI; Vélez R
P R Health Sci J; 2003 Jun; 22(2):125-9. PubMed ID: 12866135
[TBL] [Abstract][Full Text] [Related]
39. Clinical profile and outcome of classical Hodgkin lymphoma treated with a risk-adapted approach in a tertiary cancer center in India.
Parambil BC; Narula G; Prasad M; Shah S; Shet T; Shridhar E; Khanna N; Laskar S; Gujral S; Sankaran H; Banavali S
Pediatr Blood Cancer; 2020 Feb; 67(2):e28058. PubMed ID: 31724304
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.
Chang KC; Chen PC; Chang Y; Wu YH; Chen YP; Lai CH; Medeiros LJ; Su IJ; Wang HW
Histopathology; 2017 Feb; 70(3):442-455. PubMed ID: 27632954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
